Process Research and Development of Antibodies as Countermeasures for C. botulinum
Final rept. 1 Mar 2002-28 Jan 2009
NEBRASKA UNIV LINCOLN
Pagination or Media Count:
This final report describes the design and construction of a CGMP facility for yeast and bacteria on the first floor and basement of Othmer Hall, the home for the University of Nebraska-Lincoln Biological Process Development Facility. Total cost for construction was 11,165,740, with the University of Nebraska-Lincoln providing 5,179,226 46 of the funding, USAMRMC providing 4,958,049 45, and JVAP providing 1,028,465 9 . This final report also describes the expression, purification and media optimization of a monoclonal antibody against serotype A botulinum neurotoxin.
- Anatomy and Physiology
- Medicine and Medical Research